Merck reports positive results from Phase III KEYNOTE-181 trial
Merck has reported positive data from the Phase III KEYNOTE-181 trial after the study met one of its primary endpoints…
Merck Keytruda metastatic adenocarcinoma
Merck has reported positive data from the Phase III KEYNOTE-181 trial after the study met one of its primary endpoints…